Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00891111 · ClinicalTrials.gov registry record · NA
Incentives for Preventative Health Care: Increasing Completion of Health Risk Assessments
A NA study, sponsored by Carnegie Mellon University.
- Completed
- Registry status
- NA
- Development phase
- 634
- Enrollment target
NCT00891111 is a NA study that has completed, run by Carnegie Mellon University. The registered enrollment target is 634 participants.
The verdict
NCT00891111, a NA study, has completed, sponsored by Carnegie Mellon University.
- COMPLETED
- Registry status
- NA
- Development phase
- 634 participants
- Enrollment target
Study Summary
The purpose of this study is to understand using incentives to encourage employees to increase participation in an aspect of a corporate wellness program - filling out health risk assessments. This study will test whether lottery-linked incentives are more effective than guaranteed incentives in encouraging people to fill out health risk assessments. This study will be run in an employer setting in which rates of health risk assessment completion are suboptimal. This study would be conducted within a workplace setting in which the firm is divided into a number of geographically situated and functionally related subunits. The investigators will run a "complete your health risk assessment now!" program for 4 weeks. Each work unit will obtain a symbol. Every week, one symbol will be randomly drawn, publicly announced, and anyone in that work unit at the firm who has received their preventive screening would receive a $100 prize. In addition, if all of employees in that unit have completed their forms, then the prize will be increased to $125. The investigators expect this condition to result in greater compliance compared to a control condition in which employees would receive weekly reminders and a direct payment of a $25 gift card for completing the form at anytime during the 4 weeks of the study. This is analogous to direct payments that have been used by insurers to encourage completion of such forms in other contexts.
Interventions
- BEHAVIORAL Regret Lottery
- BEHAVIORAL Direct Payment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 634 participants |
| Start Date | 2009-05 |
| Est. Completion | 2009-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00891111
The ClinicalTrials.gov registry entry for NCT00891111 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 634 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carnegie Mellon University, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Regret Lottery is the first listed.
NCT00891111 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00891111 about?
NCT00891111 is a clinical study titled "Incentives for Preventative Health Care: Increasing Completion of Health Risk Assessments". The purpose of this study is to understand using incentives to encourage employees to increase participation in an aspect of a corporate wellness program - filling out health risk assessments. This study will test whether lottery-linked incentives are more effective than guaranteed incentives in enc...
What is the current status of trial NCT00891111?
This trial is currently completed. It is a NA study. The enrollment target is 634 participants. The study started on 2009-05. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00891111?
The interventions under investigation include: Regret Lottery (BEHAVIORAL), Direct Payment (BEHAVIORAL).
Who is sponsoring clinical trial NCT00891111?
This trial is sponsored by Carnegie Mellon University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.